Novag Rino (Oxymetazoline Hydrochloride)

Oxymetazoline acts as a selective alpha‑1 and alpha‑2 adrenergic receptor agonist. By stimulating these receptors on nasal blood vessels, it causes vasoconstriction, which reduces swelling of the nasal mucosa and opens the airway for easier breathing.

The appropriate dose of Novag Rino is determined by the prescribing healthcare professional. Typically, one or two sprays per nostril every 10–12 hours are recommended, but exact instructions should follow the prescriber’s guidance and product labeling.

Safety data for oxymetazoline in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks with their healthcare provider before using Novag Rino.

To order Novag Rino, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Novag Rino’s active ingredient, oxymetazoline, provides rapid, topical vasoconstriction similar to other OTC agents like phenylephrine. Oxymetazoline generally has a longer duration of action (up to 12 hours) and may be preferred for its efficacy, though all nasal decongestants share similar cautions regarding overuse.

Novag Rino should be stored at room temperature, below 25 °C, in its original packaging. Keep the container tightly closed, protect it from moisture and direct sunlight, and keep it out of reach of children.

Novag Rino is administered as a nasal spray. The user gently inserts the tip into a nostril, blocks the opposite nostril, and sprays the recommended number of sprays while breathing in gently. The product is for topical use only and should not be ingested.

Serious risks include rebound nasal congestion (rhinitis medicamentosa) with prolonged use, significant increases in blood pressure, tachycardia, arrhythmias, and rare severe allergic reactions such as anaphylaxis. Users should discontinue use and seek medical attention if these symptoms occur.

Novag Rino should not be used by individuals with known hypersensitivity to oxymetazoline or any formulation components, children under six years of age, or patients with severe hypertension, coronary artery disease, or recent nasal surgery unless directed by a physician.